FLGT vs USB · rev $283.5M vs P/E 12, rev $28.66B
Fulgent Genetics Inc (FLGT) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported FLGT revenue for 2024-12-31 was $283.5M. Net income was -$43.8M. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. FLGT currently screens at market cap $586.6M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
FLGT currently screens at market cap $586.6M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the FLGT and USB stock pages for the full models.
Not investment advice.